BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15131045)

  • 1. Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study.
    Resnick MB; Routhier J; Konkin T; Sabo E; Pricolo VE
    Clin Cancer Res; 2004 May; 10(9):3069-75. PubMed ID: 15131045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle proteins predict recurrence in stage II and III colon cancer.
    Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Catenin and p53 analyses of a breast carcinoma tissue microarray.
    Chung GG; Zerkowski MP; Ocal IT; Dolled-Filhart M; Kang JY; Psyrri A; Camp RL; Rimm DL
    Cancer; 2004 May; 100(10):2084-92. PubMed ID: 15139049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival.
    Reinartz JJ; George E; Lindgren BR; Niehans GA
    Hum Pathol; 1994 Oct; 25(10):1075-83. PubMed ID: 7927313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
    Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
    Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.
    Kersemaekers AM; Fleuren GJ; Kenter GG; Van den Broek LJ; Uljee SM; Hermans J; Van de Vijver MJ
    Clin Cancer Res; 1999 Mar; 5(3):577-86. PubMed ID: 10100709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical patterns in rectal cancer: application of tissue microarray with prognostic correlations.
    Fernebro E; Bendahl PO; Dictor M; Persson A; Fernö M; Nilbert M
    Int J Cancer; 2004 Oct; 111(6):921-8. PubMed ID: 15300804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
    Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
    Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 and beta catenin expression in chronic ulcerative colitis--associated polypoid dysplasia and sporadic adenomas: an immunohistochemical study.
    Walsh SV; Loda M; Torres CM; Antonioli D; Odze RD
    Am J Surg Pathol; 1999 Aug; 23(8):963-9. PubMed ID: 10435567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of oncogenesis in colon versus rectal cancer.
    Kapiteijn E; Liefers GJ; Los LC; Kranenbarg EK; Hermans J; Tollenaar RA; Moriya Y; van de Velde CJ; van Krieken JH
    J Pathol; 2001 Sep; 195(2):171-8. PubMed ID: 11592095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer.
    Ougolkov AV; Yamashita K; Mai M; Minamoto T
    Gastroenterology; 2002 Jan; 122(1):60-71. PubMed ID: 11781281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study.
    Resnick MB; Konkin T; Routhier J; Sabo E; Pricolo VE
    Mod Pathol; 2005 Apr; 18(4):511-8. PubMed ID: 15475928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma.
    Sinicrope FA; Hart J; Michelassi F; Lee JJ
    Clin Cancer Res; 1995 Oct; 1(10):1103-10. PubMed ID: 9815900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
    Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
    Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A; Wang NJ; Xie JP; Thorgeirsson SS
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
    Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris PS
    Histopathology; 2000 Apr; 36(4):313-25. PubMed ID: 10759945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase IIalpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow.
    Schindlbeck C; Hantschmann P; Zerzer M; Jahns B; Rjosk D; Janni W; Rack B; Sommer H; Friese K
    Int J Gynecol Cancer; 2007; 17(5):1047-55. PubMed ID: 17433065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors.
    Pai R; Nakamura T; Moon WS; Tarnawski AS
    FASEB J; 2003 Sep; 17(12):1640-7. PubMed ID: 12958170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.